FDA Updates Depo-Provera Warning Label to Include Risk of Meningioma Brain Tumors

Start
The U.S. Food and Drug Administration (FDA) has updated the warning label for the Depo-Provera birth control shot to include information about the risk of meningioma brain tumors. The label update is intended to warn doctors and patients that use of the Depo shot may be associated with the development of these tumors, particularly with longer or repeated use….
By: Hissey, Mulderig & Friend, PLLC
Previous Story

Scope of Products Requiring Proposition 65 Warnings in California Poised to Grow

Next Story

Appeals in California Personal Injury Cases: When and How to Challenge a Verdict